Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2007

Oct 2, 2007

29831_dirs_2007-10-02_6a873811-fa29-43b9-adfe-4eefd6d3e767.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2007-09-28

Reporting Person: READ IAN C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-09-28 Common Stock A 4318 Acquired 243045.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-09-28 Employee Stock Option (right to buy) $24.43 A 25000 Acquired 2017-09-27 Common Stock (25000.00) Direct
2007-09-28 Phantom Stock Units SSP $ A 186 Acquired Common Stock (186.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3985.00 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units.

F2: Each unit represents one phantom share of common stock.

F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.